KMDA
Price
$6.65
Change
-$0.18 (-2.64%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
306.49M
81 days until earnings call
NXSCF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
May 20 closing price
Capitalization
82.26M
Interact to see
Advertisement

KMDA vs NXSCF

Header iconKMDA vs NXSCF Comparison
Open Charts KMDA vs NXSCFBanner chart's image
Kamada
Price$6.65
Change-$0.18 (-2.64%)
Volume$413
Capitalization306.49M
NEXT SCIENCE
Price$0.06
Change-$0.00 (-0.00%)
Volume$20K
Capitalization82.26M
KMDA vs NXSCF Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. NXSCF commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and NXSCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (KMDA: $6.83 vs. NXSCF: $0.05)
Brand notoriety: KMDA and NXSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 0% vs. NXSCF: 68%
Market capitalization -- KMDA: $306.49M vs. NXSCF: $82.26M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. NXSCF’s [@Pharmaceuticals: Other] market capitalization is $82.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileNXSCF’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • NXSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than NXSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 5 TA indicator(s) are bullish.

  • KMDA’s TA Score: 5 bullish, 4 bearish.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -0.44% price change this week, while NXSCF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.70%. For the same industry, the average monthly price growth was +10.85%, and the average quarterly price growth was +39.68%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.70% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than NXSCF($82.3M). KMDA YTD gains are higher at: 15.365 vs. NXSCF (-21.429). KMDA has higher annual earnings (EBITDA): 22.4M vs. NXSCF (-11.94M). KMDA has more cash in the bank: 55.6M vs. NXSCF (7.37M). NXSCF has less debt than KMDA: NXSCF (276K) vs KMDA (8.82M). KMDA has higher revenues than NXSCF: KMDA (143M) vs NXSCF (10.4M).
KMDANXSCFKMDA / NXSCF
Capitalization306M82.3M372%
EBITDA22.4M-11.94M-188%
Gain YTD15.365-21.429-72%
P/E Ratio37.43N/A-
Revenue143M10.4M1,375%
Total Cash55.6M7.37M755%
Total Debt8.82M276K3,196%
FUNDAMENTALS RATINGS
KMDA vs NXSCF: Fundamental Ratings
KMDA
NXSCF
OUTLOOK RATING
1..100
646
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7895
PRICE GROWTH RATING
1..100
4665
P/E GROWTH RATING
1..100
43100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXSCF's Valuation (49) in the null industry is in the same range as KMDA (69) in the Biotechnology industry. This means that NXSCF’s stock grew similarly to KMDA’s over the last 12 months.

NXSCF's Profit vs Risk Rating (100) in the null industry is in the same range as KMDA (100) in the Biotechnology industry. This means that NXSCF’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's SMR Rating (78) in the Biotechnology industry is in the same range as NXSCF (95) in the null industry. This means that KMDA’s stock grew similarly to NXSCF’s over the last 12 months.

KMDA's Price Growth Rating (46) in the Biotechnology industry is in the same range as NXSCF (65) in the null industry. This means that KMDA’s stock grew similarly to NXSCF’s over the last 12 months.

KMDA's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for NXSCF (100) in the null industry. This means that KMDA’s stock grew somewhat faster than NXSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PICEX7.07N/A
N/A
Virtus SGA Emerging Markets Equity C
JENIX58.27N/A
N/A
Jensen Quality Growth I
SMVTX11.74N/A
N/A
Virtus Ceredex Mid-Cap Value Equity I
IGNRX15.22N/A
N/A
Macquarie Natural Resources R
CNZLX11.24N/A
N/A
Commonwealth Australia/New Zealand

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and CRDL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
N/A
CRDL - KMDA
30%
Poorly correlated
+0.94%
RDY - KMDA
29%
Poorly correlated
-0.35%
OGI - KMDA
28%
Poorly correlated
+2.24%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
+2.26%
More

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and KMDA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
N/A
KMDA - NXSCF
27%
Poorly correlated
N/A
APNHY - NXSCF
20%
Poorly correlated
N/A
MVMDF - NXSCF
12%
Poorly correlated
N/A
OMID - NXSCF
6%
Poorly correlated
N/A
MRMD - NXSCF
5%
Poorly correlated
+0.78%
More